Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Yuyuan Tan"'
Publikováno v:
Advances in Materials Science and Engineering, Vol 2015 (2015)
The renewable cationic polyelectrolyte chitosan (CH) and anionic nanomontmorillonite (MMT) layers were alternately deposited on the surface of sisal fiber cellulose microcrystals (SFCM) via layer-by-layer (LBL) self-assembly method. The structure and
Externí odkaz:
https://doaj.org/article/30ddea2c8ae34ce28713077e73a48cd4
Publikováno v:
Cureus.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9167bca1890232c2f9f0dfef5cd4c7b
https://doi.org/10.7759/cureus.31935
https://doi.org/10.7759/cureus.31935
Autor:
Chaoyang Zhang, Zili Jiang, Wanxue Sun, Yuyuan Tang, Zhanying Zhang, Changrong Shi, Xiuxiu Ruan
Publikováno v:
Biochar, Vol 6, Iss 1, Pp 1-16 (2024)
Abstract To reveal the influence of the diversity of precursors on the formation of environmental persistent free radicals (EPFRs), pomelo peel (PP) and its physically divided portion, pomelo cuticle (PC), and white fiber (WF) were used as precursors
Externí odkaz:
https://doaj.org/article/25cc916a289a4bba81e2d1698e142c30
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
BackgroundQihuang needle therapy is a newly developed acupuncture therapy to treat tic disorders in clinical practice. However, the mechanism to reduce tic severity remains unknown. Changes in intestinal flora and circulation metabolites are perhaps
Externí odkaz:
https://doaj.org/article/eca629258635411b8feb0926b84cd6d1
Publikováno v:
Approaching China's Pharmaceutical Market ISBN: 9783319155753
China’s pharmaceutical regulatory environment and policies have constantly been changing in the past few years. In this chapter, we’ll provide a brief outline of the history of China’s regulatory system, including the stages of the State Drug A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b868f672693c1c62b96ce6ff298f35ac
https://doi.org/10.1007/978-3-319-15576-0_3
https://doi.org/10.1007/978-3-319-15576-0_3
Publikováno v:
Approaching China's Pharmaceutical Market ISBN: 9783319155753
Since 2007, international multicenter clinical trial (IMCT) pathway has been one of the major approaches for international pharmaceutical companies to register their investigational drugs in China. Companies favor IMCT since it allows sharing of glob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3aa0e99055603db8237c0b49da2bae08
https://doi.org/10.1007/978-3-319-15576-0_8
https://doi.org/10.1007/978-3-319-15576-0_8
Publikováno v:
Approaching China's Pharmaceutical Market ISBN: 9783319155753
Recalling the history of China’s pharmaceutical intellectual property right (IPR) protection in the past 20 years, China adopted many international standards for pharmaceutical IPR protection. At the same time, China also issued a series of nationa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e81290ffff9377cc31f7337306511ace
https://doi.org/10.1007/978-3-319-15576-0_2
https://doi.org/10.1007/978-3-319-15576-0_2
Publikováno v:
Advances in Materials Science and Engineering, Vol 2015 (2015)
The renewable cationic polyelectrolyte chitosan (CH) and anionic nanomontmorillonite (MMT) layers were alternately deposited on the surface of sisal fiber cellulose microcrystals (SFCM) via layer-by-layer (LBL) self-assembly method. The structure and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1fe0957fd2be209091f4e2ab2aa44f6
Publikováno v:
Approaching China's Pharmaceutical Market ISBN: 9783319155753
In comparison to western pharmaceutical regulations, China’s pharmaceutical legislation started much later in history. Because of these cultural, social, and economic discrepancies, foreign pharmaceutical companies hoping to introduce their drugs t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a918dc5cc40a200fad40c65545e413eb
https://doi.org/10.1007/978-3-319-15576-0_1
https://doi.org/10.1007/978-3-319-15576-0_1
Publikováno v:
Approaching China's Pharmaceutical Market ISBN: 9783319155753
Currently, drug registrations in China follow the Provisions for Drug Registration, Order No. 28, effective since 2007. This regulation provides clear definitions and dossier application requirements for various drug categories and classes in the acc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08a925fc837ff1c2092fd02b17286773
https://doi.org/10.1007/978-3-319-15576-0_5
https://doi.org/10.1007/978-3-319-15576-0_5